Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-12

Clinical Trial Update: Recurrent and Nonrecurrent Condyloma Treatment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating a treatment for recurrent and nonrecurrent genital warts (condyloma acuminatum) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Recurrent Condyloma, Nonrecurrent Condyloma | Phase 2, Phase 3 | Status: TERMINATED